In the coming years, it is expected that the Global Parotid Tumors Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Parotid Tumors. Global Parotid Tumors market is expected to grow at a CAGR of 7.1% during the forecasted period.
MarketResearchFuture.com adds “Parotid Tumors – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.
North America Parotid Tumors market is a growing market in the Americas region. On a regional basis, Americas region is segmented into North America and South America. North America is segmented into US and Canada. Increasing number of cancer and rising consumption of alcohol among the masses is likely to drive the growth of North America Parotid Tumors market. Additionally, rising healthcare expenditure is likely to drive the growth of the market. For instance, according to National Institute on alcohol abuse and alcoholism, in 2015, around 26.9% individuals aged 18 and above are engaged in drinking.Similarly, according to Agency for Healthcare Research and Quality (AHRQ), around USD 80.2 billion was spent in cancer treatment.
Europe is the second largest market and holds a noticeable share in the global Parotid Tumors market. The European market is expected to grow a healthy growth during the forecast period owing to the availability of newer and advanced treatment facilities, and rising skilled medical professionals along with growing need for better healthcare infrastructure. Furthermore, extensive research and development activities for the treatment of disease and increasing government support and initiative boost the market growth.
Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases is the major driver for the market growth. India is the fastest growing region owing to an increasing population. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the market.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.
Some of the players in the Parotid Tumors market are Eli Lilly & Co, Bayer AG, Merck & Co. Inc., Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services, LLC, Hoffmann-La Roche Ltd, and Novartis AG.
Parotid Tumors are abnormal growth within the salivary gland. The parotid glands are prone to various conditions like fibrous reaction, parotitis, salivary stones, injury, cancers, and parotid tumors. The parotid tumor can be cancerous or non-cancerous.
Parotid Tumors can be caused by various reasons such as certain abdominal surgery, liver cirrhosis, dehydration, salivary gland infections, metastasis of cancer, and salivary duct stones.
The global parotid tumors market is majorly driven by growing prevalence of cancer, growing liver cirrhosis, and rising consumption of alcohol. Additionally, factors such as government initiatives and support, rising demand for advanced technologies and growing market players offering newer products are likely to drive the market.
According to Cancer Research U.K, around 14.1 million cases of cancer were diagnosed in 2014. Additionally, according to national cancer institute in 2014, around 14.5 million cases of cancer went undiagnosed. Such statistics has propelled the overall number of cancer cases and thereby are likely to drive the growth of global parotid tumors market.
Factors that are likely to hamper the growth of the market are the complications that will arise after the needed treatment.
The global Parotid Tumors infection market is segmented on the basis of type, treatment, diagnosis and end users.
By the type Pleomorphic Adenoma, Warthin’s Tumor and Cancerous/Malignant Tumor.
On the basis of treatment, the market is segmented into Parotidectomy, Removal of Lymph Node, Reconstructive Surgery, Radiation Therapy, and Chemotherapy.
By diagnosis, the market is segmented into X-ray, CT scan, MRI, Ultrasound, FNAC (Fine Needle Aspiration Cytology), Sialography, and others.
On the basis of the end users, the market is segmented into hospitals, Specialty centers, and Research centers.
You can get access to sample report here: https://www.marketresearchfuture.com/sample_request/5678 .
What makes our report unique?
1) An extensive research study on the Global Parotid Tumors market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Parotid Tumors market.
2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.
Major TOC of Global Parotid Tumors Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Parotid Tumors Market, By Type
Chapter 7. Global Parotid Tumors Market, By Diagnosis
Chapter 8. Global Parotid Tumors Market, By Treatment
Chapter 9. Global Parotid Tumors Market, By End User
Chapter 10. Global Parotid Tumors Market, By Region
Chapter 11. Company Landscape
Chapter 12. Company Profiles
Chapter 13. MRFR Conclusion
Chapter 14. Appendix
List of Tables:
Table 1 Parotid Tumors Industry Synopsis, 2017-2023
Table 2 Global Parotid Tumors Market Estimates and Forecast, 2017-2023, (USD Million)
Table 3 Global Parotid Tumors Market by Region, 2017-2023, (USD Million)
Table 5 Global Parotid Tumors Market by Treatment, 2017-2023, (USD Million)
Table 6 Global Parotid Tumors Market by Diagnosis, 2017-2023, (USD Million)
Table 7 Global Parotid Tumors Market by End Users, 2017-2023, (USD Million)
Table 8 North America Parotid Tumors Market by Treatment, 2017-2023, (USD Million)
List of Figures:
Figure 1 Research Process
Figure 2 Segmentation for Global Parotid Tumors Market
Figure 3 Segmentation Market Dynamics for Parotid Tumors Market
Figure 4 Global Parotid Tumors Market Share, By Treatment 2016
Figure 5 Global Parotid Tumors Market Share, By Diagnosis 2016
Figure 6 Global Parotid Tumors Market Share, By End Users, 2016
Figure 7 Global Parotid Tumors Market Share, By Region, 2016
Figure 8 North America Parotid Tumors Market Share, By Country, 2016
…CONTINUED FOR TOC
Feel free to get in touch for discounts and customized details: https://www.marketresearchfuture.com/check-discount/5678 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312